ORGANIC
LETTERS
2008
Vol. 10, No. 16
3449-3452
A New Entry to Carbocyclic
Nucleosides: Oxidative Coupling
Reaction of Cycloalkenylsilanes with a
Nucleobase Mediated by Hypervalent
Iodine Reagent
Yuichi Yoshimura,*,† Masatoshi Ohta,† Tatsushi Imahori,† Tomozumi Imamichi,‡
and Hiroki Takahata*,†
Faculty of Pharmaceutical Sciences, Tohoku Pharmaceutical UniVersity,
4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan, and Laboratory of Human
RetroVirology, Applied and DeVelopment Research Program, National Institute of
Allergy and Infectious Diseases at Frederick, Science Applications International
Corporation-Frederick, Inc., Frederick, Maryland 21702
Received May 29, 2008
ABSTRACT
A novel method for synthesizing carbocyclic nucleosides was developed. The new synthesis includes a direct coupling reaction of
cycloalkenylsilanes with a silylated nucleobase catalyzed by a hypervalent iodine reagent. By applying the method, a novel carbocyclic cytidine
derivative having bis(hydroxymethyl)cyclohexene as a pseudosugar moiety, designed as a potential anti-HIV agent, was successfully synthesized.
Carbocyclic nucleosides are a unique class of nucleosides
in which ring oxygen atoms of sugars are replaced with
methylene groups. One of the most attractive characteristics
of carbocyclic nucleosides is their antiviral activities.1–4 Since
the discovery of the potent antihuman immunodeficiency
virus (HIV) activity of carbovir 1,1 a cyclopentene ring has
been recognized as a ribofuranose equivalent for designing
new anti-HIV nucleosides. For instance, cyclopentenylcy-
tosine 22 and bis[(hydroxymethyl)cyclopentenyl]adenine
(BCA) 33 were shown to possess anti-HIV activities. A
cyclohexenyl nucleoside, a homologue of cyclopentenyl
nucleosides, is also interesting: cyclohexenylguanine 4 is
known to have anti-human herpes simplex virus type 1
(HSV-1) activity.4
As one part of our continuous study to search for new
anti-HIV agent,5 the synthesis of a novel cycloalkenyl
nucleoside was envisioned. The direct introduction of a
† Tohoku Pharmaceutical University.
‡ Science Applications International Corporation-Frederick.
(1) Vince, R.; Hua, M. J. Med. Chem. 1990, 33, 17
.
(5) (a) Yamada, K.; Sakata, S.; Yoshimura, Y. J. Org. Chem. 1998, 63,
6891. (b) Yoshimura, Y.; Asami, K.; Matsui, H.; Tanaka, H.; Takahata, H.
Org. Lett. 2006, 8, 6015. (c) Yoshimura, Y.; Yamazaki, Y.; Kawahata, M.;
Yamaguchi, K.; Takahata, H. Tetrahedron Lett. 2007, 48, 4519.
(6) Typically, Mitsunobu reaction and Pd-catalyzed cross-coupling
reaction have been used:(a) Barral, K.; Halfon, P.; Pe`pe, G.; Camplo, M.
Tetrahedron Lett. 2002, 43, 81. (b) Trost, B. M.; Li, L.; Guile, S. D. J. Am.
Chem. Soc. 1992, 114, 8745.
(2) Song, G. Y.; Paul, V.; Choo, H.; Morrey, J.; Sidwell, R. W.; Schinazi,
R. F.; Chu, C. K. J. Med. Chem. 2001, 44, 3985
.
(3) Katagiri, N.; Shiraishi, T.; Sato, H.; Toyota, A.; Kaneko, C.; Yusa,
K.; Oh-hara, T.; Tsuruno, T. Biochem. Biophys. Res. Commun. 1992, 184,
154
.
(4) Wang, J.; Froeyen, M.; Hendrix, C.; Andrei, G.; Snoeck, R.; De
Clercq, E.; Herdewijn, P. J. Med. Chem. 2000, 43, 736
.
10.1021/ol8012155 CCC: $40.75
Published on Web 07/10/2008
2008 American Chemical Society